C-reactive protein and lactate dehydrogenase serum levels potentially predict the response to checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Wei Y, Xu J, Huang X, Xie S, Lin P, Wang C, Guo Y, Zou S, Zhao Z, Wen W, Song Y, Bao Z, Zhang L, Liu W, Kong W, Wang W, He B, Zhang S, Zhou C, Chen Y, Yu Z.
Wei Y, et al. Among authors: bao z.
J Thorac Dis. 2023 Apr 28;15(4):1892-1900. doi: 10.21037/jtd-23-240. Epub 2023 Apr 17.
J Thorac Dis. 2023.
PMID: 37197527
Free PMC article.